http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22b4db3b511e9ff36654c738b9cb3832
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Landen |
| name | Charles N. Landen Charles N Landen |
| given-name | Charles N. Charles N |
| organization-name | Authors' Affiliations: 1Gene Expression and Regulation Program, The Wistar Institute; 2Histopathology Facility; 3Department of Pathology; 4Biostatistics and Bioinformatics Facility; 5Transgenic Facility; 6Women's Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 7Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; 8Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and 9Human Genetics Programme, Spanish National Cancer Research Centre (CNIO) and Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain 9Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia. University of Virginia, Department of Oncology, Division of Gynecologic Oncology, Charlottesville, VA, USA 1Gynecologic Oncology and Departments of 5Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville, Virginia. 3Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia. Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, USA Authors' Affiliations: Departments of 1Obstetrics and Gynecology, 2Radiation Oncology, and 3Pathology, University of Alabama at Birmingham, Birmingham, Alabama; 4Center for RNA Interference and Non-Coding RNA, Departments of 5Experimental Therapeutics, 6Cancer Biology, and 7Gynecologic Oncology & Reproductive Medicine, U.T.M.D. Anderson Cancer Center, Houston, Texas From the Departments of Gynecologic Oncology, Biostatistics and Applied Mathematics, and Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Virginia, Charlottesville, VA Authors' Affiliations: Departments of 1Obstetrics and Gynecology, 2Biostatistics, and 3Pathology, University of Alabama at Birmingham, Birmingham, Alabama Authors' Affiliation: Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama The Department of Pathology and Laboratory Medicine University of North Carolina at Chapel Hill, USA Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham Birmingham Alabama Department of Pathology, University of North Carolina, Chapel Hill, NC 27599. From the Department of Gynecologic Oncology and the Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Center for Cancer Research, National Cancer Institute, Bethesda, MD Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA; 1Gynecologic Oncology, Departments of Ronald J. Buckanovich, MD, PhD, University of Pittsburgh, Pittsburgh, PA; Gordon Rustin, MD, Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom; Shitanshu Uppal, MBBS, University of Michigan, Ann Arbor, MI; Alexander B. Olawaiye, MD; Joseph L. Kelley, MD; and Jessica L. Berger, MD, University of Pittsburgh, Pittsburgh, PA; and Charles N. Landen, MD, MS, University of Virginia, Charlottesville, VA Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and Departments of 2Gynecologic Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, U.T.M.D. Anderson Cancer Center, Houston, Texas Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35294, USA 1Gynecologic Oncology, and Departments of 1Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia. |
Incoming Links
Showing number of triples: 1 to 153 of 153.